Literature DB >> 18819330

The practical management of gout.

H Ralph Schumacher1, Lan X Chen.   

Abstract

Gout management requires a comprehensive strategy that considers both acute and chronic aspects of the disease. Acute gout flares should be treated with anti-inflammatory agents as rapidly as possible. The underlying hyperuricemia may be treated with urate-lowering agents initiated at a time appropriate for the individual patient. Successful urate lowering ultimately prevents flares and disease progression and should be started immediately in patients with advanced or tophaceous disease. When urate-lowering therapy is initiated, anti-inflammatory prophylaxis should be used to reduce the risk of flares induced by abrupt changes in urate levels. Regular monitoring of serum urate can ensure therapeutic dosing of urate-lowering agents to achieve levels below 6 mg/dL, which are associated with a reduction in flares and tophi.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18819330     DOI: 10.3949/ccjm.75.suppl_5.s22

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  3 in total

Review 1.  The epidemiology and treatment of gout.

Authors:  Neil W McGill
Journal:  Open Access Rheumatol       Date:  2011-12-20

2.  Changes in serum inflammatory factors in acute gouty arthritis patients treated using ultrashort wave combined with loxoprofen sodium.

Authors:  Ying Wu; Yan Wang; Wenjing Yuan; Xiangzhi Xiao; Guohua Cheng
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

3.  Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.

Authors:  Robert A Terkeltaub; H Ralph Schumacher; John D Carter; Herbert S B Baraf; Robert R Evans; Jian Wang; Shirletta King-Davis; Steven P Weinstein
Journal:  Arthritis Res Ther       Date:  2013-02-01       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.